POMS

POMS

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $17.5M

Overview

POMS Corporation is a mature, established software company operating in the digital health and AI/machine learning sectors, with a core focus on manufacturing execution systems (MES) for life sciences. Its primary product, POMSnet Aquila MES, is a purpose-built, validated software platform that digitizes and manages the manufacturing process, integrating enterprise and plant-floor systems to improve efficiency, compliance, and data integrity. With a claimed history dating back to 1988 and a significant track record of millions of completed work orders, POMS serves large pharmaceutical and biotech companies, generating revenue through software licensing, SaaS subscriptions, and support services. The company positions itself as an industry leader with deep domain expertise, offering both on-premise and cloud deployment models.

Digital HealthAI / Machine Learning

Technology Platform

POMSnet Aquila MES: A fully web-based, cloud-ready Manufacturing Execution System (MES) purpose-built for life sciences. It features an intuitive operator interface, 'review by exception' automation, and integrates ERP and plant-floor systems to create FDA-compliant electronic batch records.

Funding History

2
Total raised:$17.5M
Series A$15M
Seed$2.5M

Opportunities

The global shift towards digital manufacturing, Industry 4.0, and electronic batch records in the highly regulated pharma/biotech sector creates a large and growing market.
The rise of complex therapies like cell and gene treatments, which require meticulous tracking, presents a specific high-value expansion opportunity for POMS's specialized MES.

Risk Factors

Intense competition from larger industrial automation and ERP vendors with broader portfolios poses a significant threat.
The company also faces execution risks related to technology shifts (e.g., cloud migration), cybersecurity, and potential slowdowns in manufacturing capital expenditure which could delay client projects.

Competitive Landscape

POMS competes in the life sciences MES segment against large industrial automation firms (e.g., Siemens, Rockwell Automation), enterprise software giants (e.g., SAP), and other niche MES providers. Its competitive edge is its deep, pharma-specific expertise, a proven track record over decades, and a platform designed specifically for operator usability and regulatory compliance.